Galaxy Surfactants Limited

rs,

bai – 400 051 Scrip Symbol: GALAXYSURF BSE Limited, Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Code: 540935 Sub: Investor presentation on the Audited Financ

₹122 crore

lict, which impacted global supply chains, logistics, and input costs. EBITDA for Q4FY26 stood at ₹122 crore compared to ₹135 crore in Q4FY25, with EBITDA/MT at ₹ 20,113 versus ₹21,715 in the corresponding p

₹135 crore

obal supply chains, logistics, and input costs. EBITDA for Q4FY26 stood at ₹122 crore compared to ₹135 crore in Q4FY25, with EBITDA/MT at ₹ 20,113 versus ₹21,715 in the corresponding period last year, suppor

₹ 20,113

costs. EBITDA for Q4FY26 stood at ₹122 crore compared to ₹135 crore in Q4FY25, with EBITDA/MT at ₹ 20,113 versus ₹21,715 in the corresponding period last year, supported by effective pass-through of cost i

₹21,715

for Q4FY26 stood at ₹122 crore compared to ₹135 crore in Q4FY25, with EBITDA/MT at ₹ 20,113 versus ₹21,715 in the corresponding period last year, supported by effective pass-through of cost increases, an im

4%

high single digit YoY in Q4 due to shipment delays and elevated freight costs, while maintaining a 4% growth for the full-year. The Americas emerged as a relatively bright spot with sequential improve

3%

offsetting high-single digits decline in Performance Surfactants FY26 EBITDA remained dropped by 3% YoY to Rs 497 Cr vs Rs 510 Cr in FY25 and consequentially FY26 EBITDA / MT stood at Rs 19,357/MT

Rs 497

g high-single digits decline in Performance Surfactants FY26 EBITDA remained dropped by 3% YoY to Rs 497 Cr vs Rs 510 Cr in FY25 and consequentially FY26 EBITDA / MT stood at Rs 19,357/MT vs FY25 at Rs 1

Rs 510

digits decline in Performance Surfactants FY26 EBITDA remained dropped by 3% YoY to Rs 497 Cr vs Rs 510 Cr in FY25 and consequentially FY26 EBITDA / MT stood at Rs 19,357/MT vs FY25 at Rs 19,862/MT Ind

Rs 19,357

dropped by 3% YoY to Rs 497 Cr vs Rs 510 Cr in FY25 and consequentially FY26 EBITDA / MT stood at Rs 19,357/MT vs FY25 at Rs 19,862/MT India YoY Volume grew by high single digits on YoY basis driven by T2

Rs 19,862

497 Cr vs Rs 510 Cr in FY25 and consequentially FY26 EBITDA / MT stood at Rs 19,357/MT vs FY25 at Rs 19,862/MT India YoY Volume grew by high single digits on YoY basis driven by T2-T3 customers and Special

₹ 817.3

ormance Highlights Performance Surfactants Revenue Specialty Care Revenue Total Revenue Q4FY26 ₹ 817.3 cr FY26 ₹ 3,340.8 cr ₹ 497.6 cr ₹ 1,929.6 cr ₹ 1,315.0 cr ₹ 5,270.4 cr Volume Summary Q4FY26

Cash Flow From Operating Activities

2

Investor Relations Advisors

1

Cash Flow From Operating Activities

Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents FY26 FY25 267.4 469.3 332.7 -377.6 -51.0 -95.9 193.4 11.7 109.1 304.9 484.5 420.5 -294.6 -157.3 -31.4 220.5 4.3 193.4 12 Standalone Profit & Loss Statement Particulars (Rs. In Crores) Net Revenue from Operations Other Income Total Revenue Cost of Material Consumed Employee's Benefits Expense Other Expenses EBITDA EBITDA Margin Depreciation EBIT Finance cost PBT (Before Exceptional) Exceptional Item PBT (AfterExceptional) Tax expense PAT PAT Margin Other Comprehensive Income Total Comprehensive Income E

Cash Flow From Operating Activities

Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents FY26 FY25 152.0 272.1 94.9 -69.3 -29.1 -3.5 9.0 -0.1 5.3 173.8 282.7 295.5 -164.8 -143.6 -13.0 21.9 0.0 8.9 15 Managing Volatility in Raw Material Prices and Currency... Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 3,000 2,600 2,200 1,800 1,400 1,000 94.00 90.00 86.00 82.00 78.00 74.00 70.00 LA Price USDINR … through Robust Risk Management Practices Source: Market Prices – ICIS – LOR Source: RBI 16 Thank You Company

Investor Relations Advisors

CIN No: L39877MH1986PLC039877 Mr. Ruchir Soni Email: Ruchir.Soni@galaxysurfactants.com www.galaxysurfactants.com CIN - U74140MH2010PTC204285 Mr. Mandar Chavan / Mr. Rahul Agarwal mandar.chavan@sgapl.net / rahul.agarwal@sgapl.net +91 96993 82195 / +91 98214 38864 www.sgapl.net